Protease inhibitor combos.
D019380:Anti-HIV Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D015224:Dideoxynucleosides / Q000008:administration & dosage; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage*; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage*; D000099227:Abacavir
D019380:Anti-HIV Agents; D015224:Dideoxynucleosides; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D000099227:Abacavir